ReviewJournal of molecular histology2026
Functional roles, mechanistic insights, and therapeutic potential of the IGF2BP family in viral infections and virus-associated cancers.
Review in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The insulin-like growth factor 2 mRNA-binding protein (IGF2BP) family, comprises highly conserved RNA-binding proteins that play crucial roles in post-transcriptional gene regulation. Recent evidence suggests that IGF2BP proteins contribute to the pathogenesis and progression of multiple cancers and also participate in the regulation of viral infections and virus-associated tumors. This review provides a systematic synthesis of the biological functions of the IGF2BP family and its regulatory roles in viral life cycles. Particular emphasis is placed on oncogenic viruses, including hepatitis B and C viruses, human papilloma virus, Epstein-Barr virus, and human immunodeficiency virus, which co-opt IGF2BP proteins to promote viral replication and support tumorigenic processes. These mechanisms include the stabilization of viral RNA, modulation of host metabolic pathways, and immune responses. Furthermore, this review evaluates the therapeutic potential of targeting IGF2BP proteins in virus-associated tumors, offering new insights and future directions for research in this area.
Indexed as
Identifiers
41514070What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.